LDR | | 01526camuu2200289 a 4500 |
001 | | 000000707922 |
005 | | 20080828164116 |
008 | | 070918s2008 mdu b 001 0 eng d |
010 | |
▼a 2007038609 |
020 | |
▼a 9781847205995(hardcover):
▼c GBP69.95 |
040 | |
▼a DLC
▼c DLC
▼d 225009 |
050 | 00 |
▼a K1575
▼b .H37 2008 |
082 | 00 |
▼a 346.04/86
▼2 22 |
090 | |
▼a 346.0486
▼b 008a |
093 | 0 |
▼a 1095263
▼x 법학 |
100 | 1 |
▼a Haracoglou, Irina,
▼d 1981-. |
245 | 10 |
▼a Competition law and patents:
▼b a follow-on innovation perspective in the biopharmaceutical industry/
▼c by Irina Haracoglou. |
260 | |
▼a Northampton, MA,:
▼b Edward Elgar,
▼c 2008. |
300 | |
▼a xx, 251 p;
▼c cm. |
490 | 0 |
▼a New horizons in competition law and economics series |
504 | |
▼a Includes bibliographical references (p. 200-238) and index. |
505 | 0 |
▼a Biopharmaceutical R&D : the increased importance of cumulative innovation and related concerns -- The patent system as a system of balancing -- The patent system and some potential safety nets -- The right to health as an interpretive principle of patent law -- Unilateral conduct, IPRs and competition law : a systems' interaction -- The duty to deal under Art. 82 EC -- The duty to deal as applied to address technology access problems in the biopharmaceutical industry. |
650 | 0 |
▼a Patent laws and legislation. |
650 | 0 |
▼a Pharmaceutical biotechnology
▼x Patents. |
650 | 0 |
▼a Pharmaceutical biotechnology
▼x Law and legislation. |
650 | 0 |
▼a Competition, Unfair. |
990 | |
▼a 신정선
▼b 신정선 |